Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.8821
Nov 17 • 3:59 PM ET Dollar change+0.0794 Percentage change(9.89%)
Aftermarket Close
0.8958
Aftermarket • 6:36 PM ET Dollar change+0.0137 Percentage change(1.55%)
Index
RUT
Market Cap
88.39M
Enterprise Value
97.49M
Income
-23.60M
Sales
31.53M
Book/sh
0.21
Cash/sh
0.04
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
131
IPO
Aug 12, 2004
P/E
-
Forward P/E
-
PEG
-
P/S
2.80
P/B
4.16
P/C
22.21
P/FCF
-
EV/EBITDA
-
EV/Sales
3.09
Quick Ratio
0.66
Current Ratio
1.08
Debt/Eq
0.30
LT Debt/Eq
0.25
Option/Short
Yes / Yes
EPS (ttm)
-0.24
EPS next Y
-0.17
EPS next Q
-0.05
EPS this Y
8.00%
EPS next Y
27.54%
EPS next 5Y
-
EPS past 3/5Y
0.82% -17.98%
Sales past 3/5Y
4.78% 3.99%
EPS Y/Y TTM
15.55%
Sales Y/Y TTM
4.83%
EPS Q/Q
10.04%
Sales Q/Q
19.57%
Insider Own
23.21%
Insider Trans
0.00%
Inst Own
42.40%
Inst Trans
-2.34%
ROA
-34.99%
ROE
-117.39%
ROIC
-67.55%
Gross Margin
52.53%
Oper. Margin
-67.81%
Profit Margin
-74.86%
SMA20
-7.36%
SMA50
-20.29%
SMA200
-45.31%
Trades
Shs Outstand
100.83M
Shs Float
76.94M
52W High
2.86 -69.16%
52W Low
0.80 10.26%
Volatility
9.82% 9.90%
ATR (14)
0.10
RSI (14)
41.62
Beta
1.40
Rel Volume
1.80
Avg Volume
676.76K
Volume
1,217,365
Perf Week
-14.36%
Perf Month
-12.66%
Perf Quarter
-36.08%
Perf Half Y
-49.01%
Perf YTD
-61.65%
Perf Year
-58.39%
Perf 3Y
-43.46%
Perf 5Y
-86.74%
Perf 10Y
54.75%
Prev Close
0.80
Price
0.88
Change %
9.89%
Consensus
Strong Buy
Avg. Price Target
$2.67
Implied Upside
+202.7%
Analysts10incl. previous ratings
Rating Distribution10 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Dec 16, 2025Initiated
CCitizens JMP
Mkt Outperform$4+353.5%
Jan 10, 2024Initiated
RROTH MKM
Buy$5+466.8%
Jul 12, 2022Initiated
AAegis Capital
Buy$6+580.2%
Jun 23, 2022Initiated
RILY logoRB. Riley Securities
Buy$6+580.2%
Jan 05, 2022Initiated
LLoop Capital
Buy$13+1,373.8%
Jan 05, 2022Initiated
CCraig Hallum
Buy$11+1,147.0%
May 26, 2021Initiated
PPiper Sandler
Overweight$9+920.3%
Sep 08, 2020Initiated
NNorthland Capital
Outperform$9.50+977.0%
Apr 09, 2020Initiated
CCowen
Outperform$6+580.2%
Apr 07, 2020Initiated
LLake Street
Buy$5+466.8%
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
C.F.A.Dr. David Leo Fischel C.A.I.A.
Chief Financial OfficerMs. Kimberly R. Peery CPA
Vice President of OperationsMr. Keith Galloway
General Counsel & SecretaryMs. Patricia S. Williams Esq.